Results 111 to 120 of about 11,143 (172)

Out-of-beam artifact suppression in charged nuclear fragment based carbon-ion radiotherapy monitoring. [PDF]

Med Phys
Kirchgässner R, Martišíková M, Schlegel P, Ochoa-Parra P, Harrabi S, Jäkel O, Debus J, Kelleter L.   +7 more
europepmc   +1 more source

Factors requiring adaptive re-planning in carbon ion radiotherapy for head and neck cancers. [PDF]

Front Oncol
Yamada T, Okano N, Matsumura A, Sakai M, Shimada H, Musha A, Ohno T.   +6 more
europepmc   +1 more source

Evaluation and implementation of an independent Kilovoltage X-ray-based imaging platform for carbon ion radiotherapy. [PDF]

J Appl Clin Med Phys
Guo Y, Liu Z, Zhu Q, Cai M, Cai H, Liu R, Zhang Q, Xu Z.   +7 more
europepmc   +1 more source

Commissioning and robustness evaluation of external laser sensor for respiratory gating in carbon-ion radiotherapy. [PDF]

J Appl Clin Med Phys
Kim TH, Han S, Yoo D, Lee S, Oh T, Lee D, Kim C, Han MC, Hong CS, Kim JS.   +9 more
europepmc   +1 more source

Carbon Ion Radiotherapy for Retroperitoneal Sarcoma: A Single-Institution Study. [PDF]

Cancers (Basel)
Imai R, Yonemoto T, Araki N, Takiyama H, Ikawa H, Yamada S, Ishikawa H.   +6 more
europepmc   +1 more source

Clinical outcomes of carbon-ion radiotherapy for residual or recurrent hepatocellular carcinoma after transarterial chemoembolization. [PDF]

ESMO Gastrointest Oncol
Sekiguchi Y, Shibuya K, Tomogane S, Miyasaka Y, Kakizaki S, Okamoto M, Araki K, Shirabe K, Ohno T.   +8 more
europepmc   +1 more source

Application of intrahepatic fiducial markers in carbon ion radiotherapy for pancreatic cancer-Achieving higher precision treatment. [PDF]

J Appl Clin Med Phys
Nagata J, Kusano Y, Komori M, Takayama Y, Kurokawa S, Ito A, Kamada T, Yoshida D, Kawashiro S, Katoh H.   +9 more
europepmc   +1 more source

Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma. [PDF]

Int Cancer Conf J
Anzai H, Miwa C, Ogasawara S, Fujiya M, Kurosaki H, Tsuchiya T, Yoshino R, Katayama K, Sawada M, Akatsuka T, Izai R, Yonemoto T, Yumita S, Koroki K, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Makishima H, Shinoto M, Wakatsuki M, Yamada S, Ishikawa H, Kato J.   +23 more
europepmc   +1 more source

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol. [PDF]

BMJ Open
Koroki K, Wakatsuki M, Ogasawara S, Makishima H, Watabe T, Anzai H, Fujiya M, Sawada M, Tsuchiya T, Katayama K, Yoshino R, Izai R, Akatsuka T, Miwa C, Yonemoto T, Yumita S, Inoue M, Nakamura M, Kanogawa N, Nakamoto S, Takahashi K, Ozawa Y, Inaba Y, Kurokawa T, Isozaki T, Takahashi A, Kato J, Ohtsuka M, Ohno T, Ueno Y, Furuse J, Kudo M, Hanaoka H, Ishikawa H.   +33 more
europepmc   +1 more source

MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial. [PDF]

JHEP Rep
Ogasawara S, Koroki K, Makishima H, Wakatsuki M, Takahashi A, Fujiya M, Yumita S, Nakagawa M, Kanzaki H, Kobayashi K, Inoue M, Nakamura M, Kanogawa N, Kondo T, Nakamoto S, Kurokawa T, Ozawa Y, Inaba Y, Paritala S, Chen J, Lee J, Hoshida Y, Hanaoka H, Yamada S, Ishikawa H.   +24 more
europepmc   +1 more source